OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes
Cheng‐Han Chen, Sheng-Wen Lin, Ching‐Fen Shen, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 509-509
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 334-334
Open Access | Times Cited: 28

Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID
Emily Hadley, Yun Jae Yoo, Saaya Patel, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 11

Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants
Tudorița Gabriela Părângă, Mariana Pavel, Daniela Constantinescu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers
Alexander Liu, Robert Hammond, Peter Donnelly, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 1, pp. 21-46
Open Access | Times Cited: 15

Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients
Snježana Zeba, Maja Šurbatović, Ivo Udovičić, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 73-90
Open Access

The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients
CKN Lai, Yingfei Wang, Flair Donglai Shi, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3511-3522
Open Access

SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study
Emily Hadley, Yun Jae Yoo, Saaya Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14

Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis
Daniela Ligi, Bruna Lo Sasso, Brandon Michael Henry, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 6, pp. 960-973
Open Access | Times Cited: 14

Blood transcriptome responses in patients correlate with severity of COVID-19 disease
Ya Wang, Klaus Schughart, Tiana Maria Pelaia, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14

Clinical Spectrum of Long COVID: Effects on Female Reproductive Health
Syeda Maham, Mee‐Sup Yoon
Viruses (2024) Vol. 16, Iss. 7, pp. 1142-1142
Open Access | Times Cited: 3

Molnupiravir as an Early Treatment for COVID-19: A Real Life Study
Michela Pontolillo, Claudio Ucciferri, Paola Borrelli, et al.
Pathogens (2022) Vol. 11, Iss. 10, pp. 1121-1121
Open Access | Times Cited: 13

What is the impact of circulating histones in COVID-19: a systematic review
Daniela Ligi, Rosaria Vincenza Giglio, Brandon Michael Henry, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 10, pp. 1506-1517
Open Access | Times Cited: 12

Simultaneous determination of procalcitonin and interleukin-6 in human serum samples with a point-of-care biosensing device
Dimitra Tsounidi, Vasileios Tsaousis, Nikolaos Xenos, et al.
Talanta (2023) Vol. 258, pp. 124403-124403
Closed Access | Times Cited: 6

Histopathological examination of the placenta after delivery in pregnant women with COVID-19
Fatih Taş, Fikri Erdemci, Fırat Aşır, et al.
Journal of Health Sciences and Medicine (2022) Vol. 5, Iss. 3, pp. 868-874
Open Access | Times Cited: 10

Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody
Danay Saavedra, Ana Laura Añé-Kourí, Egda M Llanez Gregorich, et al.
Immunology Letters (2022) Vol. 251-252, pp. 1-8
Open Access | Times Cited: 9

Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon
Alex Bezerra da Silva Maciel, Arlene dos Santos Pinto, Bernardo Maia Silva, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

A complete blood count-based multivariate model for predicting the recovery of patients with moderate COVID-19: a retrospective study
Yiting Wang, Xuewen Li, Jiancheng Xu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8

Common Prognostic Biomarkers and Outcomes in Patients with COVID-19 Infection in Saudi Arabia
Mashael Abujabal, Mohamed Shalaby, Layla Abdullah, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 5, pp. 260-260
Open Access | Times Cited: 3

Green Tea Extract Reduced Lipopolysaccharide-Induced Inflammation in L2 Cells as Acute Respiratory Distress Syndrome Model Through Genes and Cytokine Pro-Inflammatory
Didik Priyandoko, Wahyu Widowati, Lenny Lenny, et al.
Avicenna Journal of Medical Biotechnology (2023)
Closed Access | Times Cited: 3

Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study
Antonio Russo, Mariantonietta Pisaturo, Ilaria De Luca, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 136-142
Open Access | Times Cited: 4

A Narrative Review of the Evaluation of Biomarkers in COVID-19 Patients Indicating the Course of the Disease
Sena ÖZCAN YILDIRIM, Gülbu Işıtmangil
Turkiye Klinikleri Journal of Medical Sciences (2024) Vol. 44, Iss. 1, pp. 43-52
Open Access

Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19
Iago Carvalho Schultz, Ana Cláudia dos Santos Pereira Andrade, Isabelle Dubuc, et al.
Stem Cell Reviews and Reports (2024)
Closed Access

PREDICTION OF THE STATE OF CRITICAL PATIENTS WITH SARS-CoV-2 INFECTION (LABORATORY ASPECT)
Anna Yushchuk, Olha Korzhyk, Василь Пикалюк
Ukrainian Journal of Laboratory Medicine (2024) Vol. 2, Iss. 3
Open Access

Dynamics of Biomarkers in COVID-19 Patients Treated with Anakinra
Ralitsa Yordanova, Dimitar Strashimirov, Rusina Grozdeva, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2690-2690
Open Access

Page 1 - Next Page

Scroll to top